Clinical Trials
70 trialsNCT04756037 2026-05-13
SERENE
Sumitomo Pharma Switzerland GmbH
Phase 3 Completed
NCT04550429 2026-04-30
Uterine Filling Pressure in Hysteroscopy
Northwestern University
Phase NA Terminated
NCT04655144 2026-01-07
Dex-Fib
University of Miami
Phase 3 Completed
NCT06429163 2026-01-06
WINPLEX
Saint Petersburg State University, Russia
Phase NA Completed
NCT05017246 2025-07-31
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
Washington University School of Medicine
Phase 2 Terminated
NCT03194646 2025-07-28
ASTEROID 6
Bayer
Phase 3 Terminated
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02777203 2024-10-24
Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy
Wake Forest University Health Sciences
Phase NA Completed
NCT00290251 2024-07-15
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03751124 2024-06-25
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03412890 2024-05-09
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03815344 2024-01-09
Combined Vaginal Misoprostol and Perivascular Vasopressin
Maimonides Medical Center
Phase 4 Completed
NCT00133705 2023-09-25
Trial of Mifepristone for Fibroids
University of Rochester
Phase 3 Completed
NCT02209545 2023-09-07
Misoprostol for Reduction of Blood Loss During Fibroid Surgery
Northwestern University
Phase 4 Terminated
NCT04177693 2023-06-05
Pharmacokinetics and Hepatic Safety of EGCG
Yale University
Phase 1 Completed
NCT03400943 2023-05-03
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)
Bayer
Phase 3 Terminated
NCT03400956 2022-06-30
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
Bayer
Phase 3 Terminated
NCT03103087 2022-04-20
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03049735 2022-04-19
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03886220 2022-03-31
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 4 Completed
NCT03317795 2021-12-08
Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
Mayo Clinic
Phase 4 Completed
NCT00731341 2021-07-19
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
Boston Scientific Corporation
Phase NA Completed
NCT01441635 2021-07-13
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
AbbVie
Phase 2 Completed
NCT02691494 2021-07-13
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
AbbVie
Phase 3 Completed
NCT02925494 2021-07-13
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
AbbVie
Phase 3 Completed
NCT01817530 2020-07-21
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
AbbVie
Phase 2 Completed
NCT02654054 2020-06-29
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02812186 2020-04-08
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Stony Brook University
Phase 4 Completed
NCT02228174 2020-02-11
SONATA
Gynesonics
Phase NA Completed
NCT02470741 2019-11-15
PLUM
University of California, San Francisco
Phase 4 Completed
NCT01629563 2019-09-04
PEARLIV
PregLem SA
Phase 3 Completed
NCT02270255 2019-08-14
Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Completed
NCT02811159 2019-06-27
An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Terminated
NCT02323646 2019-06-25
Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Completed
NCT02301897 2019-06-19
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Completed
NCT00958334 2019-06-18
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
Repros Therapeutics Inc.
Phase 2 Completed
NCT00131365 2019-06-12
Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids
InSightec
Phase NA Completed
NCT02147158 2019-06-04
A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas
Allergan
Phase 3 Completed
NCT02147197 2019-04-30
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Allergan
Phase 3 Completed
NCT02655224 2019-03-22
A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids
Takeda
Phase 3 Completed
NCT02655237 2019-03-22
A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids
Takeda
Phase 3 Completed
NCT01142791 2019-03-19
Safety Study of ExAblate for the Treatment of Uterine Fibroids
InSightec
Phase NA Completed
NCT01285960 2019-03-06
ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids
InSightec
Phase NA Completed
NCT00365989 2019-02-05
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
InSightec
Phase 3 Completed
NCT00730886 2018-08-15
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
InSightec
Phase NA Terminated
NCT02227316 2018-06-08
Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure
University of California, Los Angeles
Phase 4 Completed
NCT02192606 2018-01-24
3DRCT
Brigham and Women's Hospital
Phase NA Completed
NCT02131662 2017-12-08
ASTEROID 1
Bayer
Phase 2 Completed
NCT01152112 2017-09-13
HOME
Hologic, Inc.
Phase NA Completed
NCT01369758 2017-09-13
MyoSure Hysteroscopic Tissue Removal System Registry Study
Hologic, Inc.
Phase NA Completed